Does the patient's immunoglobulin subtype (IgA, IgG, IgM) impact myeloma prognosis and treatment strategies?

Does the patient's immunoglobulin subtype (IgA, IgG, IgM) impact myeloma prognosis and treatment strategies?
Which supplements might be helpful for myeloma patients and should be discussed with their doctor to ensure they're safe and appropriate?
What are point mutations in genes? How do they differ from chromosomal mutations? Consequences?
What are some tips for coping with the fear of relapse?
What should I know about the t(11;14) in myeloma?
What is Mass Spec ? What is the MASS-FIX blood test?
What neurotoxicities are associated with T-cell therapies? How are these toxicities managed? What is the risk of delayed toxicity?